Explain The Key Points Of The Disease Theoretical Model

Explain The Key Points Of The Disease Theoretical Model Of Addictione

Explain the key points of the disease theoretical model of addiction. Explain two strengths and two limitations of this theoretical model. Explain the major contributions of this theoretical model to the field of addiction treatment. Explain whether the limitations that you identified may affect the applicability of the model in the treatment of addiction and why. Use Marge from the media piece as an example.

Paper For Above instruction

The disease theoretical model of addiction, often referred to as the biomedical or medical model, conceptualizes addiction primarily as a chronic disease of the brain. This perspective emphasizes that addiction is not merely a behavioral issue or a lack of willpower but a medical condition characterized by biological, psychological, and genetic factors that alter brain structure and function. The model posits that individuals with addiction have a physiological dependency on substances or behaviors, which results from neurochemical changes in the brain's reward, motivation, memory, and related circuits. These changes impair an individual's ability to exert voluntary control over their cravings and behaviors, leading to compulsive engagement despite adverse consequences.

One of the core tenets of this model is that addiction is a progressive disease with relapsing potential. It recognizes that relapse is a common feature due to the persistent neurobiological alterations. This understanding underpins the rationale for medical interventions, such as pharmacotherapy, in conjunction with behavioral therapies. Medications like methadone, buprenorphine, and naltrexone are utilized to stabilize brain chemistry, reduce cravings, and prevent relapse, highlighting the model’s focus on biological underpinnings of addiction.

A significant strength of the disease model is its ability to destigmatize addiction. By framing addiction as a chronic illness rather than a moral failing, it encourages empathy and compassion, leading to increased acceptance of those affected and facilitating engagement with treatment. This perspective promotes the view that individuals with addiction require medical and psychological support rather than punishment, potentially improving treatment adherence and outcomes.

Another advantage is the model’s influence on treatment approaches. It has led to the development of evidence-based pharmacological interventions that can effectively help manage and treat addiction. The recognition of addiction as a disease has also fostered integrated care models that combine medication management with counseling and behavioral therapies, offering comprehensive treatment plans tailored to individual needs.

Despite these strengths, the disease model has limitations. One significant criticism is that it may oversimplify addiction by focusing predominantly on biological components and potentially neglecting social, environmental, and psychological factors essential to understanding and treating addiction. For example, environmental stressors, trauma, and social context profoundly influence the development and persistence of addictive behaviors, which this model may underemphasize.

A second limitation concerns individual agency and responsibility. By emphasizing the neurobiological basis of addiction, the model might inadvertently diminish personal responsibility, possibly leading to a passive approach to treatment. Some critics argue that this perspective could undermine motivation for behavioral change and relapse prevention, as it might emphasize biological determinism over factors like motivation, social support, and behavioral interventions.

The contributions of this model to addiction treatment are substantial. It has transformed perceptions of addiction from a moral weakness to a treatable medical condition, prompting increased investment in research and clinical interventions. The model has also facilitated the development of medication-assisted treatments (MAT), which have proven effective in reducing relapse rates and supporting recovery.

However, the limitations of the disease model may impact its applicability in real-world treatment settings. For instance, reliance solely on pharmacotherapy may neglect the importance of addressing social determinants of health, such as housing, employment, and social support, which are critical for sustained recovery. When considering Marge from the media piece, her case illustrates this point: while medication may help manage her physiological dependence, addressing underlying psychological trauma, environmental stressors, and social support networks would be vital components for long-term recovery.

In conclusion, the disease theoretical model of addiction emphasizes the biological and neurochemical aspects of addiction, providing valuable insights and treatment options. Nevertheless, its limitations in considering social and psychological contexts highlight the need for a holistic approach in addiction treatment to maximize recovery chances. A comprehensive model that integrates biological, psychological, and social factors can better serve individuals like Marge, supporting sustainable recovery and improved quality of life.

References

- National Institute on Drug Abuse. (2020). The Science of Drug Use and Addiction: The Basics. NIH. https://www.drugabuse.gov/publications/media-guide/science-drug-use-addiction-basics

- Kidd, P. M. (2018). Pharmacological treatment of addiction: Current status and future directions. Journal of Clinical Pharmacology, 58(2), 153–161.

- McLellan, A. T., Lewis, D., O'Brien, C., & Kleber, H. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA, 284(13), 1689–1695.

- Volkow, N. D., & Morales, M. (2015). The Brain on Drugs: From Reward to Addiction. Cell, 162(4), 712-725.

- Harvey, M. (2017). Rethinking addiction: A biopsychosocial perspective. Addiction Research & Theory, 25(4), 297-308.

- Lembke, A. (2018). Why addiction is not a disease. The New York Times. https://www.nytimes.com/2018/03/16/opinion/addiction-disease.html

- McHugh, R. K., & Weiss, R. D. (2019). Evidence-Based Psychosocial Treatments for Substance Use Disorders. Psychiatric Clinics, 42(2), 253-261.

- Carter, P. M., & Craig, T. K. (2010). Environmental and social influences on substance use and addiction. Psychology & Health, 25(4), 455-468.

- World Health Organization. (2019). Management of Substance Use Disorders. WHO Press.

- Hodge, D. R., & Turner, J. (2017). Ethics and addiction treatment: The importance of social justice. Social Work, 62(3), 235-241.